ARTICLE | Company News
Genzyme, Imperial Cancer Research Fund deal
January 29, 1996 8:00 AM UTC
GENZ will work with ICRF's Imperial Cancer Research Technology Ltd. company to identify gene therapy projects targeted at cancer. GENZ will fund any selected projects in exchange for commercial rights...